Vimarsana
Biggest News Aggregation in the World

Page 24 - Immunic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Today - Breaking & Trending Today

Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer - Vimarsana News

Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

DGAP-News: Immunic, Inc. to Participate in Investor and Scientific Conferences in March - Vimarsana News

DGAP-News: Immunic, Inc. to Participate in Investor and Scientific Conferences in March

DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in March 08.03.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in Investor and Scientific Conferences in March N...

Immunic, Inc. to Participate in Investor and Scientific Conferences in March - Vimarsana News

Immunic, Inc. to Participate in Investor and Scientific Conferences in March

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...

DGAP-News: Immunic, Inc. to Participate in Investor and Scientific Conferences in March - Vimarsana News

DGAP-News: Immunic, Inc. to Participate in Investor and Scientific Conferences in March

DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in March 08.03.2022 / 12:30 The issuer is solely responsible

Immunic, Inc. to Participate in Investor and Scientific Conferences in March - Vimarsana News

Immunic, Inc. to Participate in Investor and Scientific Conferences in March

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...